Shadi Tabibian: Understanding Thrombotic Risk in Rare Bleeding Disorders
Shadi Tabibian, Deputy of Research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Journal, adding:
“I am pleased to share our newly published article in Thrombosis Journal:
‘Thrombosis in rare bleeding disorders: a bleeding phenotype does not fully preclude thrombotic risk.’
Thrombosis in patients with rare bleeding disorders is uncommon, but clinically important and potentially life-threatening.
In our cohort of 1,251 patients, 12 individuals (0.96 percent) experienced imaging-confirmed thrombosis.
All events were venous and occurred mainly in high-risk clinical settings, including pregnancy, surgery, infection, and exposure to replacement therapy.
The key message is clear: having a bleeding disorder does not eliminate thrombotic risk.
Recognizing prothrombotic triggers and carefully individualizing anticoagulation and replacement therapy are essential for safe patient management.
I am grateful to my co-authors and all the patients and clinical teams who contributed to this work.”
Title: Thrombosis in rare bleeding disorders: a bleeding phenotype does not fully preclude thrombotic risk- frequency, clinical contexts, and management in a large Iranian cohort
Authors: Majid Naderi, Saeedeh Yaghoubi, Sina Rajaee, Ilia Mirzaei, Shadi Tabibian

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery